Tag Archive: Events

  1. Novel 3D Biomaterials for use in Advanced Therapies

    Leave a Comment

    If you are interested in Advanced Therapies, please come join us in Barcelona on March 18, 2019 for a masterclass on “Advanced Therapies Research, Development and Collaboration”, organised by Advance (Cat)and the Cell and Gene Therapy Catapult (UK), in partnership with the UK Department for International Trade (DIT)and Creatio.

    This masterclass event offers the opportunity for you to hear Advanced Therapies experts cover crucial aspects necessary to go from research to clinical application and product development. Top experts from Spain and the UK will share their experience and we welcome an interactive session with lots of networking time in order to have the opportunity to meet with you.

    We will be presenting Biogelx technologyas a tool that enables the generation of 3D cellular models for research applications in Advance Therapies. The possibility of utilizing Biogelx materials to model specific cellular/tissue environments provides a valuable tool for Stem Cell Therapyand Tissue Engineering.

    To attend please email usor register here.


    March 18, 2019, 15:00

    Aula Magna – Faculty of Medicine and Health Sciences (Universitat de Barcelona), C/ Casanova 143, Barcelona

  2. Advanced in vitro models analysis – TEDD Annual Meeting 2018

    Leave a Comment

    During the past two decades, we have witnessed significant scientific and technical advances in the fields of drug discovery and translational medicine along with advances in predictive in vitro model systems. As of now, microfabrication techniques and tissue engineering have enabled the development of a wide range of 3D cell culture technologies, including multicellular spheroids, organoids, scaffolds, hydrogels, organs-on-chips, and 3D bioprinting, each with its own advantages and disadvantages. 3D culture models have been penetrating into the early drug discovery process, starting from disease modeling to target identification and validation, screening, lead selection, efficacy, and safety assessment.

    This year’s TEDD Annual Meeting brings together experts from diverse fields with a shared interest in advanced 3D models. The idea is to help to foster collaborations between 3D cell culture developers, and experts in advanced analysis methods: microscopy, sensors, data modelling, and high-throughput screening. Several companies will exhibit during our famously long lunch break at the Greenhouse, where we have the opportunity to interact. Join us for this meeting to celebrate another fruitful collaboration year with the new perspectives ahead.

    Thermo Fisher Scientific – Biogelx – Promega – Imactiv-3D – ABC Biopply ag – StemCell Technology – Hit Discovery – Bachem – Binder – Greiner Bio-One GmbH – Cellbox Solutions – LOT-QuantumDesign – Bio-techne – Optics11 – Biotek

    Program: click here



    You might like:

    3D In-Vitro Tumor Models Are Changing Cancer Research and Drug Discovery

    Not all 3D Cultures are Created Equally – Which is the best one for you?

    4 Signs Your 3D Cell Culture Needs Upgrading


  3. Meet with us at CPhI 2018

    Leave a Comment

    CPhI Worldwide, the world’s largest pharma trade show, drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market.

    This year, CPhI Worldwide will host more than 45,000 visiting pharma professionals, 2,500+ exhibitors from 153 countries during 9 – 11 October in Madrid, Spain. Biogelx will exhibit within the  Scottish Pavillion (Hall 9 – Stand J40) and will present the company’s innovative 3D Cell Culture and Bioink technology.

    If you are visiting the event, please make sure to stop by and meet our representatives, Elia Lopez-Bernardo, PhD and Sandy Bulloch for a chance to discuss the applications of Biogelx products in drug discovery and regenerative medicine.

    If you want to secure time to speak with Elia and Sandy, please click here and arrange a meeting.


    You might like:

    Behind the scenes: R&D and Innovation at Biogelx

    3D In-Vitro Tumor Models Are Changing Cancer Research and Drug Discovery

    Would you like to collaborate with Biogelx?


    Upgrading your project using peptide hydrogels

  4. Biogelx at BioSpain on 25 September

    Leave a Comment

    Biogelx is attending BioSpain in Seville on September 25-27. We would love to meet up with you there! If you attend, make sure to reach out to hear more about our 3D cell culture platform and new inks for bioprinting!

    Click here and schedule a meeting with Elia!

    BioSpain is the largest biotech event organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings (+3.000) delegates (+1800) and companies participating (+800). BioSpain 2018 is part of the European Biotechnology Week.

    Looking forward to all the partnering sessions and presentations!


  5. Advanced in vitro models and Bioengineered Cancer Tissue

    1 Comment

    Our CEO, Mitch Scanlan, our Director of Strategic Collaboration, Sandy Bulloch, and our new Development Scientist, Christopher Allan are attending the “‘Engineered Tissues for Discovery Industry Day and Workshop” at the University of Glasgow today. The event, organised by the University Cell and Biomedical Engineers Team aims to discuss research findings, existing and future studies in bioengineered tissue and advanced in vitro models. The projects presented at the event are focused on understanding the interactions between biomaterials, proteins, and cells to engineer and control cell behaviour and stem cell differentiation.

    The event has many industrial/charitable/policy attendees including Adumatech, Animal-Free Foundation UK, Astra Zeneca, Biogelx, Biolamina, Bone Cancer Research Trust, Cell Guidance Systems, Charles River Laboratories, Censo, Clyde Biosciences, Collagen Solutions, Cytochroma, Cytomos, the Electrospinning Company, Evotec/Cyprotex, Hyaltech, Macbio consultants, NC3Rs, Reprocell, Sartorius, SNBTS, Strathroslin, Sygnature and Terumo Aortic.